Integrated BioTherapeutics
Integrated BioTherapeutics Inc (IBT) is an emerging research-based company dedicated to development of vaccines and discovery of small molecules targeting emerging infectious agents.
We are located in Germantown, Maryland. IBT has experience and a close working arrangement with many of the United States government agencies including the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), National Cancer Institute (NCI), National Institute of Health (NIH), and the Department of Defense (DOD). Furthermore, IBT has established cooperative working relationships with Becton Dickinson (BD) for development of vaccines against staphylococcal infections, Omrix for development of antibody products against staphylococcal and streptococcal infections, and Functional Genetics for development of antivirals against viral hemorrhagic fevers.
Recent News
May 15, 2009
Integrated BioTherapeutics Wins "2009 Emerging Company of the Year" at Tech Council of Maryland Annual Awards Celebration
…read more
October 2, 2008
Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses
…read more
June 25, 2008
IBT wins the "Incubator Company of the Year Award" 2008 as Best Life Science Company.
…read more
June 25, 2008
Integrated BioTherapeutics, Inc. will move its laboratory and office space to Germantown, MD.
…read more
June 25, 2008
Integrated BioTherapeutics was awarded a $4.7M from NIH to continue research aimed at development of an immunotherapeutic against one of the toxins of Staphylococcus aureus.
…read more
May 5, 2008
Integrated BioTherapeutics has been nominated one of three finalists for the “annual Maryland Incubator Company of the Year Awards” in the category “Life Science Companies”.
…read more
